2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine

We are 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine CAS:253168-94-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 253168-94-4
Product Name: 2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine
Other Name:
2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine
1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine
1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethylamine
3-Ethoxy-4-methoxy-alpha-[(methylsulfonyl)methyl]-benzenemethanamine
Apremilast Intermediate I
 
Density: 1.2±0.1 g/cm3
Boiling Point: 469.6±45.0 °C at 760 mmHg
Molecular Formula: C12H19NO4S
Molecular Weight: 273.349
Flash Point: 237.8±28.7 °C
Exact Mass: 273.103485
PSA: 87.00000
LogP: 0.65
Vapour Pressure: 0.0±1.2 mmHg at 25°C
Index of Refraction: 1.528
 
Specification
Appearance: White to off-white powder
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Apremilast CAS: 608141-41-9.
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-(3-ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine


Related News: With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.4072-67-7 With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.1- (3-bromofenil) -2-fenil-1H-benzo [d] imidazol CAS:1171247-63-4 Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.O-(2,4-dichlorophenyl) chloromethanethioate CAS:2812-86-4 Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.

Related Products
Product Name
2,4-Dichloro-5-(trifluoromethyl)pyrimidine View Details
1,8-Dibromooctane View Details
(3aS,4S,6aR)-4-methoxy-tetrahydro-furo[3.4-b]furan-2(3H)-one View Details
ethyl (2Z)-2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate manufacturer 2-dimethylphosphanylethyl(dimethyl)phosphane manufacturer o-Toluoyl chloride manufacturer 2-Chloro-4-methoxy-5-nitropyridine manufacturer ethyl 2-(7-methoxynaphthalen-1-yl)acetate manufacturer